Cite
MLA Citation
M V Lenti et al.. “P352 A propensity score-matched, real-world comparison of ustekinumab vs vedolizumab as a second-line treatment for Crohn's disease. The Cross Pennine study II.” Journal of Crohn's and colitis, vol. 15, n.d., pp. S372–S373. http://access.bl.uk/ark:/81055/vdc_100130765034.0x00001b